Zydus Lifesciences Limited — Others, 29-11-2024: Action(s) taken or orders passed

Zydus Lifesciences Limited has received a Demand Order-In-Original concerning ITC carried forward through TRAN-1 for the financial year 2017-18, totaling ₹16.12 million, which includes a demand of ₹8.06 million and an equal penalty. The company plans to challenge this order through an appeal. However, it anticipates no material financial impact from this situation. Investors may view this as a neutral impact, given the company’s proactive stance to contest the demand and the lack of significant financial repercussions.